(Q46551181)

23 December 2017

title

CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

29 October 2022

0 references

3

H. A. Whiteford

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689187

29 October 2022

author name string

W. O. Faustman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689187

29 October 2022

K. F. Faull

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689187

29 October 2022

C. Borchert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689187

29 October 2022

J. G. Csernansky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1689187

29 October 2022

language of work or name

English

0 references

publication date

1 February 1990

1 reference

23 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:000632239090005M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

https://api.elsevier.com/content/article/PII:000632239090005M?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

29 October 2022

published in

Biological Psychiatry

1 reference

23 December 2017

volume

27

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

311-318

1 reference

23 December 2017

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

CSF monoamine metabolites in melancholia

29 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

29 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Aggression, suicide, and serotonin: relationships to CSF amine metabolites

29 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Neuroendocrine and neurochemical measurements in depression

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

A diagnostic interview: the schedule for affective disorders and schizophrenia

29 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

A rating scale for depression

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Influence of age on the cortisol response to dexamethasone.

29 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Dexamethasone bioavailability: implications for DST research

29 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Dexamethasone suppression test status and severity of depression

29 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness

29 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?

29 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Depressive symptoms associated with dexamethasone resistance

29 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

CSF amine metabolites and depression

29 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Acting out hostility in normal volunteers: negative correlation with levels of 5HIAA in cerebrospinal fluid.

29 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

29 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

29 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Increased serotonin-2 binding sites in frontal cortex of suicide victims

29 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides

29 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

CSF monoamine metabolites of depressed patients during illness and after recovery

29 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Central serotonin metabolism and frequency of depression

29 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

The severity of depression and nonsuppression on the DST

29 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

Elevated baseline and postdexamethasone cortisol levels

29 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

The effect of age on baseline and postdexamethasone cortisol levels in major depressive disorder

29 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

The validity of the dexamethasone suppression test as a marker for endogenous depression

29 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(90)90005-M

29 October 2022

Identifiers

1 reference

23 December 2017

1 reference

23 December 2017